CBA
KRON

Coastal Bridge Advisors’s Kronos Bio KRON Stock Holding History

Coastal Bridge Advisors’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-51,968
Closed -$52K – 170
2024
Q3 		$52K Hold
51,968
– – 0.01% 169
2024
Q2 		$64.4K Hold
51,968
– – 0.02% 160
2024
Q1 		$67.6K Hold
51,968
– – 0.02% 170
2023
Q4 		$65K Hold
51,968
– – 0.02% 164
2023
Q3 		$67.6K Hold
51,968
– – 0.02% 156
2023
Q2 		$89.4K Hold
51,968
– – 0.02% 156
2023
Q1 		$75.9K Hold
51,968
– – 0.02% 157
2022
Q4 		$84.2K Hold
51,968
– – 0.02% 159
2022
Q3 		$174K Hold
51,968
– – 0.05% 148
2022
Q2 		$189K Hold
51,968
– – 0.06% 139
2022
Q1 		$376K Hold
51,968
– – 0.09% 100
2021
Q4 		$706K Sell
51,968
-26,667
-34% -$417K 0.15% 82
2021
Q3 		$1.65M Sell
78,635
-36,000
-31% -$773K 0.38% 40
2021
Q2 		$4.75M Buy
+114,635
New +$2.9M 0.97% 17

Other funds holding KRON

VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Coastal Bridge Advisors's KRON Position: Q4 2024 in Review

Coastal Bridge Advisors sold out of Kronos Bio (KRON) in Q4 2024, closing a stake of 51,968 shares — an estimated $52K sold.

Coastal Bridge Advisors first reported a position in KRON in Q2 2021 and held it in 14 quarters. The position peaked at $4.75M in Q2 2021. 56 funds tracked by Wall St. Rank hold KRON as of Q4 2024.

  • Coastal Bridge Advisors reported no remaining Kronos Bio position as of Q4 2024 after selling out during the quarter.
  • Coastal Bridge Advisors sold 51,968 Kronos Bio shares in Q4 2024, an estimated $52K.
  • Coastal Bridge Advisors first reported a position in Kronos Bio in Q2 2021 and held it in 14 quarters.
  • Coastal Bridge Advisors's Kronos Bio position peaked at $4.75M in Q2 2021.
  • 56 funds tracked by Wall St. Rank held Kronos Bio as of Q4 2024.

Based on Coastal Bridge Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.